Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T13:30:21.337Z.
Calculation as of: 2026-10-06T13:30:21.337Z.
Quote observation: 2026-10-06T13:30:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fa223cd5a0006a47bd3f11d3634c651a1c818c2f8beb58cb941cded2cdd6eca8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Adial Pharmaceuticals, Inc.
Market Cap
$11.50M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.27M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.21M
Operating Cash Flow Yield
N/A
TTM Avg
42.53%
3Y Avg
42.53%
5Y Avg
42.53%
Market Cap
$10.74M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.94M
Operating Cash Flow Yield
N/A
TTM Avg
10.50%
3Y Avg
10.50%
5Y Avg
10.50%
Market Cap
$11.95M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | $11.50M | N/A | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.27M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | N/A | 42.53% | 42.53% | 42.53% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $10.74M | N/A | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $11.94M | N/A | 10.50% | 10.50% | 10.50% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $10.86M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.75M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.74M | N/A | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.79M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
